Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost for Nail Growth and Brittleness
NCT02448043Completed
- Sponsor
- Northwestern University
- Start
- Jun 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of bimatoprost in onychomadesis and onychoschizia (2 arms), sponsored by Northwestern University. Primary endpoints: Change From Baseline in Nail Length of Hands at 30 days, Change From Baseline in Nail Length of Digits at 30 days and 2 more. Started Jun 2015; status: completed.
02
Drugs
bimatoprost
03
Conditions
onychomadesisonychoschizia
Beyond the preview
Go deeper on NCT02448043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448043.